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Tyrosyl-DNA phosphodiesterase (Tdp1) is a DNA 3′-end processing enzyme that repairs
topoisomerase 1B-induced DNA damage. We use a new tool combining site-speciﬁc
DNA–protein cross-linking with mass spectrometry to identify Tdp1 interactions with DNA. A
conserved phenylalanine (F259) of Tdp1, required for efﬁcient DNA processing in bio-
chemical assays, cross-links to deﬁned positions in DNA substrates. Crystal structures of
Tdp1–DNA complexes capture the DNA repair machinery after 3′-end cleavage; these reveal
how Tdp1 coordinates the 3′-phosphorylated product of nucleosidase activity and accom-
modates duplex DNA. A hydrophobic wedge splits the DNA ends, directing the scissile strand
through a channel towards the active site. The F259 side-chain stacks against the −3 base
pair, delimiting the junction of duplexed and melted DNA, and ﬁxes the scissile strand in the
channel. Our results explain why Tdp1 cleavage is non-processive and provide a molecular
basis for DNA 3′-end processing by Tdp1.
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Normal DNA metabolism can create lesions that, if notrepaired, can lead to genome instability, contributing todiseases including cancer and neuropathies1. Knowing
how DNA is damaged and how cells deal with damaged DNA is
not only important for understanding the aetiology of these
diseases, but it can also be exploited for anti-cancer therapy.
Broken DNA strands, created by exogenous or endogenous
DNA damage, often contain lesions that block their 3′ or 5′ ends.
These must be removed before the broken strand can be repaired.
The DNA repair enzyme tyrosyl-DNA phosphodiesterase 1
(Tdp1) removes 3′-blocking lesions and then protects 3′ ends
from further degradation during DNA repair. Tdp1 confers a
neuroprotective function in vivo2, by facilitating single-strand
break repair in neurons. A mutation in the Tdp1 active site causes
the rare neurodegenerative disorder spinocerebellar ataxia with
axonal neuropathy3.
Human Tdp1 repairs DNA damage created by topoisomerase 1
(Top1)4–7, an enzyme that relaxes superhelical tension in DNA.
To enable strand rotation, Top1 generates a temporary single-
strand break (SSB), by covalently attaching to the DNA 3′-end at
the SSB via a phosphotyrosine bond. Normally the Top1–DNA
complex is transient, but if it persists, the SSB can become a
cytotoxic DNA double-strand break (DSB), for example, during
DNA replication8,9 or RNA transcription10–12. Camptothecin
(CPT)-based anticancer therapies exploit this weakness to pro-
mote the death of rapidly replicating cancer cells. By intercalating
between Top1 and the nicked DNA, they stall Top1–DNA
complexes13 and prevent DNA religation14.
Tdp1 hydrolyses the 3′-phosphotyrosine linkage between Top1
and DNA (Fig. 1a), releasing Top1 and preventing DSBs. Thus,
Tdp1 counters the action of CPT-based cancer therapies and is
therefore a promising target to augment chemotherapy15,16. The
development of drugs to inhibit Tdp1 function will be informed
by understanding how Tdp1 interacts with and processes phy-
siological DNA substrates.
Tdp1 can also process a variety of other physiological, phar-
macological and synthetic phospho-DNA adducts. These include
3′-phosphoglycolates17 (Fig. 1b), produced by exogenous oxida-
tive DNA damage; unmodiﬁed DNA with a 3′-hydroxyl end18
(Fig. 1c); and chain-terminating nucleoside analogues (CTNAs)
(Fig. 1d), such as acyclovir, zidovudine (AZT) and cytarabine—
widely used antiviral or anticancer drugs that target DNA poly-
merases19. Tdp1−/− cells are hypersensitive to these treatments
and accumulate DNA damage, implicating Tdp1 in repair of
CTNA-induced DNA damage in vivo20. Furthermore, Tdp1
cleaves synthetic 3′-adducts (such as artiﬁcial biotin, ﬂuorophores
and black hole quenchers), used to dissect Tdp1’s activity
in vitro18,21 and to screen for Tdp1 inhibitors16,22.
After removing a 3′-blocking lesion, Tdp1 leaves a 3′-phos-
phate on the DNA end, which it cannot hydrolyse further18.
Thus, Tdp1 cleavage is non-processive. The 3′-phosphate protects
the DNA end before downstream enzymes (e.g., polynucleotide
kinase phosphatase) convert it to a 3′-OH, prior to repair by DNA
polymerases and ligases.
X-ray crystal structures gave initial insights into the mechan-
ism by which Tdp1 cleaves DNA–phosphotyrosine bonds23–26.
These revealed the architecture of the active site and how it
coordinated a transition-state intermediate mimic, comprising a
Top1-derived peptide connected to a short single-stranded DNA
via a vanadate ion25. Only three unpaired nucleotides were
observed in a narrow, positively charged cleft extending from the
Tdp1 active site. However, the DNA component of a biological
Tdp1 substrate is most likely a nicked double-stranded spe-
cies27,28, as shown in Fig. 1a. How Tdp1 recognises the duplex
structures of normal substrates is therefore an open question.
We use an integrated structural approach to establish how
Tdp1 accommodates physiological DNA substrates. We develop a
new tool to identify Tdp1–DNA interactions by combining site-
speciﬁc cross-linking of protein to modiﬁed DNA with mass
spectrometry. The ﬁndings are validated by two new crystal
structures of Tdp1 in complex with duplex DNA, which capture
the DNA repair machinery after 3′-end cleavage. These reveal
how a hydrophobic loop separates the DNA strands. Coordina-
tion of the 3′-phosphorylated DNA end in the active site and
stacking of a well-conserved phenylalanine against the −3 base
ﬁxes the scissile strand position and ensures that 3′-cleavage by
Tdp1 is not processive. Our results explain how Tdp1 removes
blocking lesions on duplex or single-stranded DNA and provide a
structural basis for Tdp1’s ability to protect 3′-phosphorylated
DNA ends.
Results
Site-speciﬁc protein–DNA cross-links and mass spectrometry.
We developed a new protocol (Fig. 2) using site-speciﬁc UV
cross-linking of DNA to protein, combined with mass spectro-
metry to identify residues in human Tdp1 that are in close
proximity to speciﬁc positions in substrate DNA. Tdp1-bound
oligonucleotides containing the photoactivatable nucleotide 5-
Iodouracil (5IdU)29,30 and a 3′ biotin-TEG tag were covalently
cross-linked to proximal aromatic amino acids by irradiation with
UV at 312 nm. By changing the position of the 5IdU on the DNA,
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Fig. 1 Tdp1 is a DNA 3′-end processing enzyme. Schematic representation
of Tdp1 activity (represented by scissors) on biologically and medically
relevant substrates. All Tdp1 reactions result in DNA with a 3′-
phosphorylated end. a Hydrolysis of the phosphotyrosyl linkage between a
proteolytic topoisomerase 1 fragment and the 3′-end of the DNA at a nick. b
Removal of glycolate from 3′ overhangs with a phosphoglycolate (PG)
adduct. c Tdp1 nucleosidase activity on unmodiﬁed DNA with a 3′-hydroxyl
end. d Removal of chain-terminating nucleoside analogues (CTNAs), such
as AZT (zidovudine) from a recessed 3′ end
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different Tdp1–DNA cross-links were formed. In this way
interactions between the known DNA positions and the protein
can be identiﬁed and mapped.
The application of chemical cross-linking with mass spectro-
metry (XLMS) to mapping protein–DNA interactions is con-
siderably less well established31,32 than techniques for analysing
protein–protein or protein–RNA interactions33,34. This is mainly
due to challenges in achieving speciﬁc protein–DNA cross-links
without background protein–protein cross-linking and with low
yields of cross-linked heteroconjugates35. Our PD-XLMS protocol
(Fig. 2) incorporates new enrichment and puriﬁcation steps that
overcome these issues.
First, cross-linked Tdp1–DNA heteroconjugates were enriched
by capturing Tdp1 via its hexa-histidine tag on magnetic beads,
concomitantly removing non-cross-linked DNA. Tdp1–DNA
heteroconjugates were then digested with trypsin, releasing
peptide–DNA heteroconjugates from the beads. Heteroconjugates
were enriched by binding to monomeric avidin via the 3′ biotin-
TEG tag, at the same time removing non-conjugated peptides.
Subsequently, samples were characterised by our previously
described mass spectrometry protocol36: analysis by LC/MS in
negative mode identiﬁed Tdp1 peptide–DNA heteroconjugates.
Then, after nuclease P1 digestion, tandem MS enabled the Tdp1
amino acid cross-linked to DNA to be identiﬁed.
Tdp1 cross-links to modiﬁed nucleobases via F259. To establish
site-speciﬁc cross-links, 20-mer single-stranded DNA oligonu-
cleotides containing 5IdU at either the −2 or the −3 position, or
unmodiﬁed as a control (Fig. 3a and Table 1), were incubated
with truncated Tdp1 (amino acids 149–608), hereafter referred to
as Tdp1(Δ148). Use of the catalytic mutant H263A Tdp1(Δ148)
ensured that the 3′ biotin-TEG, a non-physiological substrate of
Tdp118, was not removed by the enzyme. Following UV irra-
diation, reactions were analysed by SDS-PAGE and visualised by
phosphorimaging (Fig. 3b, upper panel, and Supplementary
Fig. 1A) and SimplyBlueTM staining (Fig. 3b, lower panel, and
Supplementary Fig. 1B). 32P-labelled species migrating more
slowly than the substrate DNA were predicted to be hetero-
conjugates in which either the −2 or the −3 5IdU oligonucleotide
was speciﬁcally cross-linked to Tdp1(Δ148) (lanes 2 and 3,
Fig. 3b, upper panel). These species were absent in the control
reaction performed with the unmodiﬁed oligonucleotide (lane 1,
Fig. 3b, upper panel). The species also migrated more slowly than
free, non-cross-linked Tdp1(Δ148) protein on SimplyBlueTM-
stained SDS-PAGE (Fig. 3b, lower panel), consistent with for-
mation of heteroconjugates. Thus, Tdp1(Δ148) was speciﬁcally
cross-linked to the modiﬁed 20-mer oligonucleotides.
Next, we used mass spectrometry to conﬁrm the generation of
Tdp1(Δ148)–DNA heteroconjugates and to identify which Tdp1
peptides were cross-linked to the modiﬁed −2 and −3
nucleobases. Both the −3 and −2 5IdU cross-linked samples
contained UV-absorbing species, eluting between 15 and 17 min
from a reverse-phase column (Fig. 3c), that were consistent with
peptide–DNA heteroconjugates. The corresponding masses of the
most abundant potential heteroconjugates in this time interval
were 7927.11 Da and 7912.11 Da in the −3 and −2 cross-linked
samples, respectively (Fig. 3d). Importantly, these species were
absent in the control sample. From these data, we calculated the
mass of the peptide cross-linked, by subtracting the mass of each
oligonucleotide (−3, 6882.19 Da and −2, 6867.19 Da) minus HI
(127.91 Da), which is lost during cross-linking. The mass
difference in both cases corresponds to the mass (1173 Da) of
the Tdp1(Δ148) tryptic peptide sequence L255DIAFGTHATK265.
To sequence the cross-linked peptide and to identify exactly
which Tdp1(Δ148) amino acids were cross-linked to the 5IdU-
modiﬁed nucleotides, Tdp1(Δ148) peptide–DNA heteroconju-
gates were digested with nuclease P1 to reduce the DNA moiety
to a single nucleotide monophosphate. Using high-resolution
tandem mass spectrometry, these digested species were then
detected (Fig. 3e) and sequenced (Fig. 3f). A unique [M+2H]2+
ion with m/z 740.33 was detected in both the −3 and −2 cross-
linked samples, which was absent from the control (Fig. 3e). This
ion corresponds to the mass of a heteroconjugate composed of
the Tdp1(Δ148) peptide L255DIAFGTHATK265 cross-linked to
deoxyuracil monophosphate (dUMP). Collision-induced
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Fig. 2 PD-XLMS method for site-speciﬁc protein–DNA cross-linking with mass spectrometry. Tdp1(Δ148) protein (blue, H263A inactive mutant) is cross-
linked to DNA (black line) containing 5-Iodouracil (5IdU) and a 3′-Biotin-TEG (depicted as B in a red circle). Small blue circles represent Tdp1 amino acids
(after trypsin digestion) and the red star indicates the site of the cross-link
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fragmentation of the heteroconjugates (Fig. 3f) revealed that for
the −2 cross-linked sample, the dUMP was attached to Tdp1
(Δ148) via F259. Further conﬁrming this cross-link, in the MS
spectrum shown in Fig. 3e, we also detected and fragmented the
[M+3H]3+ ion (m/z 493.89) of this cross-link. Additionally, we
detected the [M+2H]2+ and [M+3H]3+ ions (m/z 892.36 and m/z
595.24, respectively) of a heteroconjugate between F259 and a
nucleotide dimer of dUMP and the adjacent dTMP, following
incomplete digestion of the DNA. The F259 residue also cross-
links to substrates containing 5IdU at the −3 position in an
identical fashion (Supplementary Fig. 2).
Efﬁcient DNA processing requires F, W or Y at position 259.
To establish if F259 is important for Tdp1(Δ148) activity in vitro,
we substituted F259 with alanine, tryptophan or tyrosine and
compared the ability of wild-type (WT) Tdp1(Δ148) and the
F259A, F259W and F259Y mutants to cleave a 3′ quencher in
ﬂuorescence-based assays. Two DNA substrates were used: an 18
nt single-stranded DNA (Fig. 4a) and a double-stranded DNA
hairpin containing 15 base pairs (Fig. 4b and Supplementary
Fig. 3). Each substrate had a 5′ ﬂuorophore and a 3′ quencher that
ablates ﬂuorescence (Table 1). As the 3′ quencher is removed by
WT Tdp1(Δ148), ﬂuorescence increases and reaches a steady-
state level (Fig. 4c, d). Direct comparison of ﬂuorescence intensity
as a function of time with two different substrates is not possible
due to the different environments of the ﬂuorophores in the
substrates. Substitution of the active site histidine H263 with
alanine prevents Tdp1(Δ148) cleavage of the 3′ quencher and
provides a negative control.
Reactions using the F259A Tdp1(Δ148) mutant were more
than ﬁvefold slower than those using WT Tdp1(Δ148), for both
substrates. Using the single-stranded substrate at 25 °C, the
steady-state ﬂuorescence was achieved after 8 min with WT Tdp1
(Δ148) and after 40 min with the F259A mutant (Fig. 4c). By
contrast, the reactions using the double-stranded DNA hairpin
substrate reached steady state after 35 min with WT Tdp1(Δ148),
but reached only 75% of the steady-state maximum ﬂuorescence
after 90 min with the F259A mutant (Fig. 4d). We conclude that
F259 is important for efﬁcient cleavage of both single- and
double-stranded DNA substrates.
To assess whether the aromaticity or the hydrophobicity of
F259 was crucial for efﬁcient processing, we also compared the
cleavage activity of WT Tdp1(Δ148) with the F259W and F259Y
mutants. These mutants incorporate a similarly aromatic but less
hydrophobic amino acid at position 259. The activity of the
F259W Tdp1(Δ148) mutant was similar to WT enzyme on both
substrates (Fig. 4c, d). However, reactions using the F259Y Tdp1
(Δ148) mutant were 1.5 times faster than WT reactions, reaching
steady state after 5 min with the single-stranded substrate (Fig. 4c)
and after 23 min with the double-stranded DNA hairpin substrate
(Fig. 4d). Thus, we conclude that the presence of an aromatic
amino acid at position 259 is more important than the
hydrophobicity of the ring for efﬁcient processing of both single-
and double-stranded DNA substrates.
Crystallisation of Tdp1(Δ148) complexes with duplex DNA. To
establish how Tdp1 recognises duplex DNA structures, we
determined two X-ray crystal structures of Tdp1(Δ148) bound to
duplex DNA. Tdp1(Δ148):DNA complexes were assembled by
mixing the protein in a 1:1 molar ratio with 12-mer duplex DNA
(Fig. 5a and Supplementary Fig. 4). Two different DNA sequences
were designed, containing either guanine or thymine at the −2
position, and cytosine or adenine at the −11 position, but being
otherwise identical (Fig. 5b and Table 1). The Tdp1(Δ148)
complexes formed with these oligonucleotides are referred to as
−2G or −2T, respectively. Each DNA sequence was self-com-
plementary, so that annealing created a duplex with identical ends
and twofold symmetry. Thus, regardless of which DNA duplex
orientation was captured by the Tdp1 active site, identical com-
plexes would be produced.
Crystals of Tdp1(Δ148) in complex with either duplex DNA
grew in 4 days in the P21212 space group. The −2G Tdp1(Δ148):
DNA complex diffracted X-rays to 2.04 Å, whereas the −2T
complex diffracted to 3.18 Å. The X-ray diffraction and reﬁne-
ment statistics are shown in Table 2. Each crystallographic
asymmetric unit contains two Tdp1(Δ148) molecules: one has
captured a DNA duplex, whereas the other has not. The DNA-
bound and the DNA-free Tdp1(Δ148) molecules have similar
structures and can be superimposed with a r.m.s.d. of 0.33 Å over
432 Cα atoms (Supplementary Fig. 5). Each DNA duplex
Table 1 Sequences of the oligonucleotides used in the cross-linking, ﬂuorescence and crystallisation experiments
Name Sequence (5′–3′) Length (nt)
Tdp1(Δ148)–DNA cross-linking
Control 32P-GTAGAGGATCTAAAAGACTT-Biotin-TEG 20
5IdU(−2) 32P-GTAGAGGATCTAAAAGAC(5IdU)T-Biotin-TEG 20
5IdU(−3) 32P-GTAGAGGATCTAAAAGA(5IdU)TT-Biotin-TEG 20
Fluorescence quenching assays
HEI-40 56-FAM/AGA GGA TCT AAA AGA CTT/3BHQ 18
HEI-50 56-FAM/AAG TCT TTT AGA TCC CTC CGG ATC TAA AAG ACT T/3BHQ 34 (15 nt hairpin)
Crystallisation
−2G 12-mer CACTGCGCAGTG 12
−2T 12-mer CAATGCGCATTG 12
14-mer marker CACTGTCGACAGTG 14
16-mer marker CACTGTCTAGACAGTG 16
Gel analysis of crystals
12-mer substrate CACTGCGCAGTG 12
11-mer marker CACTGCGCAGT 11
10-mer marker ACTGCGCAGT 10
9-mer marker CTGCGCAGT 9
8-mer marker TGCGCAGT 8
7-mer marker GCGCAGT 7
Modiﬁcations are 32P—5′ radioactive phosphate; Biotin-TEG—a 3′ Biotin adduct attached via a triethyleneglycol linker; 56-FAM—5(6)-carboxyﬂuorescein; 3BHQ—the Black Hole Quencher
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-02530-z ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:24 |DOI: 10.1038/s41467-017-02530-z |www.nature.com/naturecommunications 5
connects two symmetry-related Tdp1(Δ148) molecules (Fig. 5c
and Supplementary Fig. 6) and the interactions of each half of the
duplex with Tdp1(Δ148) are equivalent. Therefore, we consider
henceforth only one half of the 12-mer DNA duplex. We refer to
the 3′ half, with the sequence 5′-GCA(G/T)TG-3′, as the scissile
strand and to its complement as the complementary strand.
Crystals contain the Tdp1 nucleosidase reaction product. The
2.04 Å resolution crystal structure of the Tdp1(Δ148) complex
with −2G duplex DNA is shown in Fig. 5c. Tdp1(Δ148) folds into
two α−β−α domains, as previously described23,24. The active site,
which comprises three pairs of conserved histidines, lysines and
asparagines (H263, H493, K265, K495, N283 and N516), coor-
dinates the 3′ end of the scissile DNA strand (Fig. 5d and Sup-
plementary Fig. 7). Although the DNA substrate contained a 3′
guanine (0G), the electron density clearly indicates the 3′
nucleotide is phosphorylated thymine. The phosphate oxygens
are within hydrogen bonding distance of H263 Hε (2.8 Å), H493
Hε (2.8 Å), K265 NHζ (3.2 Å), K495 NHζ (2.5 Å), N516 NH2
(2.9 Å) and N283 NH2 (3.1 Å) (Fig. 5d). The 3′-phosphate adopts
tetrahedral geometry, in contrast to the trigonal bi-pyramidal
coordination of the vanadate in the quaternary complex that
mimics the transition state25 (Supplementary Fig. 8). Based on
this result, we hypothesised that, during preparation and crys-
tallisation of the nucleoprotein complex, Tdp1(Δ148) removed
the terminal 3′ 0G nucleoside, leaving a 3′-phosphate on the
terminal −1T nucleotide. This represents a Tdp1 product
complex.
To conﬁrm Tdp1 nucleosidase activity on the 12-mer, we
incubated a 32P-labelled 12-mer DNA duplex with Tdp1(Δ148)
(Fig. 6a, b, lane 1). This generated a 3′-phosphorylated 11-mer
(Fig. 6b, lane 2), the expected product of Tdp1 nucleosidase
activity. When separated by denaturing PAGE (Fig. 6b and
Supplementary Fig. 9), the 3′-phosphorylated 11-mer (lane 2)
migrates similarly to the 10-mer marker (lane 5). In contrast,
adding Tdp1(Δ148) to an unlabelled 12-mer DNA duplex and
subsequently 32P-labelling, the nucleosidase product using
polynucleotide kinase (PNK) generates an 11-mer with a 3′OH
(Fig. 6c, b, lane 3). This is because PNK removes the 3′-
phosphate37 created by Tdp1(Δ148) nucleosidase activity as well
as adding 32P at the DNA 5′-ends.
The three nucleotides at the 5′ end of the complementary
strand (C, A and C) were not visible in the crystal structure of the
−2G Tdp1(Δ148):DNA complex. Therefore, to establish the
length of the DNA contained within the crystals, we washed a
single crystal in mother liquor and dissolved it in water (Fig. 6d).
Following incorporation of 32P with PNK, the DNA species were
separated by denaturing PAGE and the bands compared with the
products of the Tdp1(Δ148) reactions described above. The
dissolved crystals contained four distinct DNA species (Fig. 6b,
lane 9). The main species (labelled w) comprised 60% of the
mixture and migrated similarly to the 3′OH 11-mer DNA marker
(lane 4), consistent with removal of the 3′ nucleoside by Tdp1
(Δ148) during ~80 days incubation in crystallo, prior to
treatment with PNK (Fig. 6b, lane 3). The next most abundant
DNA species in the crystal (labelled x) comprised 27% of the
sample, and migrated similarly to both the 3′-phosphorylated 11-
mer (lane 2) and the 10-mer marker with a 3′OH (lane 5). This
species may have arisen from removal of the 3′ nucleoside by
Tdp1(Δ148), but with retention of the 3′P following PNK
treatment, due to reduced 3′-phosphatase activity in suboptimal
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Fig. 4 Tdp1(Δ148) activity assays. a Schematic of the activity assay using a single-stranded ﬂuorescence-quenched DNA substrate. Tdp1(Δ148) cleavage
of the 3′ quencher (purple ellipse) increases ﬂuorescence of the 5′ ﬂuorophore (black dot). b Schematic of the activity assay using a ﬂuorescence-
quenched hairpin substrate. c Plots of ﬂuorescence intensity, in relative ﬂuorescence units (RFU), against time in assays using the single-stranded DNA
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conditions. Minor DNA species, labelled y and z (totalling 13%),
migrated to the same extent as the 9-mer and 8-mer DNA
markers, respectively. These may have resulted from minor
shorter species present in the substrate (lane 1) or from
nucleolytic degradation during prolonged incubation in the
crystal. Taken together, these results support our hypothesis that
the DNA contained in the crystal is the product of Tdp1(Δ148)
nucleosidase activity and is longer than the 8 nt for which density
is observed in the crystal structure. We conclude that this new
Tdp1(Δ148):DNA co-crystal structure is a novel snapshot of the
Tdp1 reaction product.
Tdp1(Δ148) accommodates duplex DNA. The normal in vivo
DNA substrate of Tdp1 is likely a nicked duplex (Fig. 1a). But
only three nucleotides of single-stranded DNA were seen in
previous crystal structures of Tdp1(Δ148) transition-state inter-
mediate complexes (Fig. 7a). By contrast, our new co-crystal
structures reveal how Tdp1(Δ148) interacts with double-stranded
DNA (Fig. 7b, c). Both strands are recognised by the charge
complementarity of the protein surface to the DNA backbone
atoms. Bases −5G, −4C and −3A of the scissile strand pair with
the complementary strand. However, Tdp1(Δ148) separates the
strands and prevents the pairing of the DNA bases at the 0, −1
and −2 positions. The 3′-end of the scissile strand is routed into a
narrow, positively charged cleft (blue surface) towards the active
site (Fig. 7b, c).
In the −2G Tdp1(Δ148):DNA structure, eight complementary
strand nucleotides were seen (Fig. 7b). However, nine comple-
mentary strand nucleotides, as well as the phosphate backbone
and ribose atoms of −1A, are clearly deﬁned by electron density
in the lower resolution −2T Tdp1(Δ148):DNA structure (Fig. 7c).
As the position of the −1A base in the −2T Tdp1(Δ148):DNA
structure was ambiguous, we modelled this nucleotide as abasic.
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Fig. 5 Crystallisation and X-ray structure of Tdp1(Δ148) in complex with dsDNA. a 20% (w/v) native polyacrylamide gel of DNA oligonucleotides stained
with methylene blue. Lanes 1 and 2: single-stranded (ss) 12-mer and 16-mer, respectively; lanes 3 and 4, double-stranded (ds), self-complementary 12-mer
and 14-mer, respectively. b Sequences of the self-complementary 12-mers used in crystallisation, containing either a G:C or a T:A base pair at the −2
position. The black ellipse indicates the centre of the palindrome. c Ribbon representation of the crystal structure showing two symmetry-related Tdp1
(Δ148) molecules bound to one DNA duplex. The black ellipse indicates crystallographic twofold rotational symmetry. d Close-up view of the Tdp1(Δ148)
active site with catalytic residues labelled. Hydrogen bonds to the 3′-phosphorylated thymine (−1T) are shown as orange dashed lines and the water
molecule as a red sphere. The 2Fo−Fc electron density map is shown as a blue mesh contoured at 1.6σ
Table 2 Data collection and reﬁnement statistics (molecular
replacement)
Tdp1(Δ148) in
complex with −2G
DNA duplexa
Tdp1(Δ148) in complex
with −2T DNA duplexa
Data collection
Space group P21212 P21212
Cell dimensions
a, b, c (Å) 108.01, 195.31, 50.83 109.2, 198.19, 51.32
α, β, γ (°) 90, 90, 90 90, 90, 90
Resolution (Å) 52.05–2.04
(2.09–2.04)b
99.1–3.18
(3.56–3.18–2.04)
Rsym 0.067 (1.304) 0.315 (1.518)
I/σI 15.3 (1.3) 4.7 (1.4)
Completeness (%) 99.2 (97.7) 100.0 (100.0)
Redundancy 9.6 (7.1) 8.4 (8.4)
Reﬁnement
Resolution (Å) 52.05–2.04 99.1–3.18
No. reﬂections 69045 19558
Rwork/Rfree 0.232/0.272 0.250/0.306
No. atoms
Protein 6894 7062
Nucleic acid 169 199
Water 57 0
B-factors
Protein 56.6 74.1
Nucleic acid 67.6 94.7
Water 62.7 −
R.m.s. deviations
Bond lengths (Å) 0.010 0.090
Bond angles (°) 1.26 1.37
a One crystal per structure
b Values in parentheses are for highest-resolution shell
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The 5′ 0C nucleotide was not visible in either structure and we
presume it is present but disordered. This conclusion is consistent
with our analysis of dissolved crystals (Fig. 6b), which shows the
loss of the 3′ nucleoside (0G) only.
Route of the complementary DNA strand. Salt bridges and
charge–charge interactions between the complementary DNA
strand and Tdp1(Δ148) stabilise the co-crystal structure. The
complementary strand backbone atoms follow a track of positive
charges on the Tdp1(Δ148) surface (Fig. 7d) created by the side-
chain amino or guanidinium groups of K231, R232, R361 and
K527. The K232 amino group is in close proximity to the O3
bridging phosphate oxygen (3.1 Å) and the ribose ring oxygen
(3.2 Å) of −2A; while the NHε of R361 can form a salt bridge with
the non-bridging phosphate oxygen of −5C (3.6 Å). The backbone
amide of K527 hydrogen bonds with the non-bridging phosphate
oxygen of −6G (2.9 Å, Fig. 7e) and the NH2ζ is 4.2 Å from the
non-bridging phosphate oxygen of −5C. Consistent with this
structural role, K527 is highly conserved in Tdp1 sequences
(Fig. 7f), being substituted by R in Saccharomyces cerevisiae,
which could have a similar stabilising function in that species.
K527 is part of a surface-exposed β-turn between the anti-
parallel β-strands β15 and β16, which spans amino acids 527–530
(Fig. 7e). In the duplex DNA-bound Tdp1(Δ148) structures,
K527 and N528 adopt different conformations compared to
previous structures containing single-stranded DNA (super-
imposed in Fig. 7e, PDB ID: 1NOP). This conformational change
exposes a more electropositive surface along the DNA-binding
cleft (Fig. 7b, c), enabling stabilising interactions between Tdp1
and the complementary strand to form. Lower B-factors of the β-
turn residues, in comparison to the ssDNA bound structure
(indicated by colour in Fig. 7e), reﬂect an ordering of the β-turn
upon duplex DNA binding. Together, these structural differences
are consistent with the β-turn strengthening the binding of Tdp1
to duplex DNA.
A hydrophobic wedge separates the DNA duplex. Tdp1(Δ148)
physically blocks the pairing of the DNA bases at the 0, −1 and −2
positions using a hydrophobic loop formed by residues 257–261
(Fig. 8a). This loop precedes the active site histidine, H263, and
its hydrophobic character is conserved from yeast to man (Sup-
plementary Fig. 10). The aromatic ring of F259 intercalates
between the −2 and −3 scissile strand bases, forming a π–π stack
with the −3 base and demarcating the junction of melted and
duplex DNA. Consistent with this structural role, F259 is strictly
conserved in other Tdp1 sequences (Supplementary Fig. 10) apart
from Schizosaccharomyces pombe Tdp1, which has W at the
equivalent position. Our in vitro cleavage assays (Fig. 4) show that
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Fig. 6 Tdp1(Δ148) nucleosidase activity and analysis of the DNA content of Tdp1(Δ148):DNA crystals. Reaction schemes depicting a 32P-labelling of a 12-
mer DNA duplex with PNK, followed by removal of the 3′-nucleoside by Tdp1(Δ148) (star denotes 32P). b Denaturing PAGE of the products of the
reactions shown in A (lane 2) and B (lane 3). The four distinct species in the PNK-treated dissolved crystals (lane 9) are labelled from w to z. Lanes 4–8
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Tdp1 with W at position 259 has similar cleavage activity to WT
enzyme and thus likely performs a similar π−π stacking role to
F259.
Our crystal structures support the results of the in-solution
cross-linking mass spectrometry experiments, which identiﬁed
short-range site-speciﬁc interactions between F259 and modiﬁed
nucleobases at the −2 and −3 positions (Fig. 3). The role of
F259 is also consistent with the results of our in vitro biochemical
assays, which show that an aromatic amino acid side chain at
position 259 is required for efﬁcient DNA 3′-end processing
(Fig. 4) of both single- and double-stranded substrates.
We envisage that, for cleavage of the single-stranded DNA
substrate, the key role of the aromatic amino acid at 259 is
to intercalate between nucleobases −2 and −3 and to position
to scissile strand in the active site for cleavage. However,
cleavage of a double-stranded substrate involves additional
reshaping of the substrate, including separation of the two
strands of the DNA duplex by the hydrophobic loop and
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Fig. 7 Crystal structures of Tdp1(Δ148)–DNA. a Quaternary transition-state complex of Tdp1(Δ148), ssDNA (orange), a Top1-derived peptide (pink) and
vanadate (PDB ID: 1NOP). b Tdp1(Δ148) in complex with the −2G DNA duplex (PDB ID: 5NW9). c Tdp1(Δ148) in complex with the −2T DNA duplex (PDB
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stabilisation of the melted conformation by π–π stacking with the
aromatic ring of F259.
Discussion
The results presented here for Tdp1(Δ148) interactions with
DNA demonstrate the power of PD-XLMS for dissecting
protein–DNA interactions in a biological system, especially in
combination with high-resolution crystal structures and bio-
chemical activity assays. Incorporating a single photoactivatable
nucleotide at a deﬁned position within the DNA substrate allows
site-speciﬁc cross-linking to protein. This eliminates any ambi-
guity in the cross-link site within the DNA and enables identi-
ﬁcation of the directly attached amino acid by mass spectrometry.
By moving the position of the modiﬁed base along the DNA,
many different non-covalent protein–DNA interactions can be
stabilised and then characterised. In this way, sites of
protein–DNA interactions can be mapped and a model of DNA-
binding developed.
Our method of PD-XLMS also offers other advantages.
Performing cross-linking with low-energy UV radiation
minimises DNA photo-damage and maintains the native
3D structure of the DNA–protein complex. Unique to our
approach, heteroconjugates were selectively enriched prior
to mass spectrometry by avidin capture of biotin-tagged DNA.
Unlike titanium dioxide-based enrichment32,38, our method
is not limited to small nucleic acid moieties and is not hindered
by simultaneous enrichment of charged peptides. Our recently
developed mass spectrometry methods36 allowed us to observe
heteroconjugates in both negative and positive ion mode.
Here, mass spectrometry was performed on an FT-ICR MS
instrument, but heteroconjugates can also be detected by an
Orbitrap instrument. Thus, we envisage that this PD-XLMS
method will be widely applicable to dissecting the molecular
mechanisms of other biologically relevant protein–DNA
transactions.
Taken together, our structural, biochemical and biophysical
results reveal how Tdp1(Δ148) engages a physiological DNA
duplex and removes a 3′-nucleoside to produce a 3′-phosphory-
lated DNA end. They also suggest a structural mechanism for the
lack of enzyme processivity, which is crucial to Tdp1’s function in
protecting 3′-phosphorylated DNA ends.
Tdp1 removes 3′-DNA lesions from a diverse range of DNA
structures, independent of DNA sequence. It cleaves 3′-phos-
photyrosine bonds faster from blunt-ended duplexes than single-
stranded DNA substrates in vitro, but binds to each substrate
with similar afﬁnity39. By contrast, nicked or 5′-tailed duplex
DNA substrates are cleaved poorly in vitro (with a turnover rate
tenfold lower than single-single-stranded substrates). These
ﬁndings are consistent with removal of Top1 peptides attached at
3′-termini of DSBs, formed after collision of the SSB with a
replication fork4,40, as well as Top1 peptides attached at chro-
mosomal single-strand breaks. In support of this, human Tdp1
interacts directly with DNA ligase IIIa and co-
immunoprecipitates with PNK and XRCC1, suggesting that
Tdp1 acts within a complex as part of a SSB repair pathway27.
Interestingly, both Saccharomyces cerevisiae Tdp1, and to a lesser
extent human Tdp1, are also able to cleave topoisomerase 2-
associated 5′-tyrosyl DNA adducts41,42.
Our new Tdp1(Δ148)–DNA co-crystal structures show how
duplex DNA is accommodated by Tdp1(Δ148). This differs from
a previous binding model in which the DNA duplex was pro-
posed to bend away from the narrow DNA-binding channel39.
Our co-crystal structures show that, apart from the surface-
exposed β-turn between β15 and β16 (Fig. 7e), Tdp1(Δ148) does
not change its shape signiﬁcantly upon duplex DNA binding.
Instead, it sculpts the DNA. Tdp1(Δ148) separates the scissile and
complementary DNA strands in the vicinity of the cleavage site,
using a hydrophobic loop and intercalation of an aromatic amino
acid (F259) to disrupt Watson–Crick base pairing and base-pair
stacking. In a similar fashion, other nucleases (e.g., Mre11, Nﬁ)
use alpha helical hydrophobic wedges to locally reshape their
DNA substrates and to permit incision43. Thus, our results sug-
gest that local melting of the DNA by the Tdp1 hydrophobic loop
is required for and permits 3′ DNA-end processing.
The Tdp1(Δ148)–DNA co-crystal structures provide snapshots
of the 3′-phosphate product of Tdp1 nucleosidase activity bound
in the enzyme’s active site. As such they extend our knowledge of
the enzyme’s mechanism, beyond its tyrosyl-DNA phosphodies-
terase activity. Although Tdp1 removes 3′ nucleosides much less
efﬁciently than 3′-phosphotyrosines, phosphoglycolates or
CTNAs20, this activity may nevertheless have a biological role. In
Saccharomyces cerevisiae, Tdp1 nucleosidase activity was pro-
posed to mediate error prevention during NHEJ44. By generating
and binding tightly to the 3′-phosphate end, the main function of
Tdp1 may be to protect the exposed 3′ terminus while the NHEJ
machinery assembles44. In support of this proposal, Tdp1 inter-
acts functionally with the NHEJ core factor proteins XLF and
Ku70/80, which are recruited to the sites of DSBs45. Thus, the
nucleosidase activity of Tdp1 may be important for DNA repair.
Tdp1 removes one nucleoside only from a 3′-hydroxyl DNA
end, leaving a terminal 3′-phosphate. Our results explain, at a
molecular level, why this reaction product is not further hydro-
lysed by Tdp1. Progressive advancement of the scissile DNA
strand (by one nucleotide) into the narrow ssDNA-binding
protein channel would be required for the Tdp1 cleavage product
to become the next substrate for enzymatic cleavage. This would
also require release of the terminal 3′-phosphate from the active
site and separation of the −3 base pair. However, by abutting the
ds/ssDNA junction, F259 impedes such a movement (Fig. 8a, b):
DNA intercalation and π−π stacking of the F259 aromatic ring
against the −3A base acts as a wedge, lodging the strand in
position and preventing further separation of the duplex. At the
other end of the narrow channel, interactions of the 3′-phosphate
with the active site residues secure the position of the DNA 3′-end
(Fig. 8a). By ﬁxing the strand in this way, processive degradation
F259
-1T
3′P
-2G
-3A
-4C
-5G
T261
G260
A258
I257
-3T
-4G
-5C
OH
Tdp1
OH
H263
K265
N283
H493
K495
N516
Tdp1
3′P
a b
Fig. 8 A hydrophobic wedge containing F259 disrupts base pairing and
separates the DNA strands. a Close-up view of the hydrophobic wedge
residues (I257–T261) with the scissile (orange) and complementary
(green) DNA strands, shown as sticks. b Schematic representation of Tdp1
(Δ148) 3′ DNA processing and the role of the hydrophobic wedge
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of the 3′ end by Tdp1 is prevented, which is essential for Tdp1’s
biological function in DNA repair.
Methods
Tdp1(Δ148) mutation, expression and puriﬁcation. N-terminally truncated
Tdp1(Δ148), comprising amino acids 149–608, was expressed in E. coli strain BL21
(DE3) from the plasmid pHN1894s Δ1–148 with a N-terminal hexa-histidine
tag23,46. Site-directed mutagenesis (Quikchange, Stratagene) of the Tdp1(Δ148)
gene generated the substitutions F259A, F259W, F259Y and H263A. Recombinant
Tdp1(Δ148) proteins were puriﬁed on phosphocellulose P11 resin (Whatman)
followed by nickel afﬁnity chromatography. Crude cell extract was loaded onto the
P11 resin at 1 ml min−1. The buffer contained 30 mM potassium phosphate pH 7
and 100mM KCl for loading, 400 mM KCl for washing and 800 mM KCl for
elution. Fractions containing Tdp1 (Δ148) were dialysed against 0.5 M NaCl, 10
mM imidazole, 20 mM Tris pH 7.9, 0.2 mM PMSF and loaded onto a Hi-Trap
Chelating column (1 ml, GE Healthcare). The column was washed with 25 ml of
wash buffer (0.5 M NaCl, 30 mM imidazole and 20 mM Tris pH 7.9) and Tdp1 was
eluted with 5 ml of buffer containing 0.5 M NaCl, 1 M imidazole and 20 mM Tris
pH 7.9. For storage, proteins were exchanged into buffer containing 50 mM Tris
pH 7.5, 50 mM KCl, 2 mM DTT and 50% (v/v) glycerol and ﬂash frozen at −80 °C
at a ﬁnal concentration of 55 μM.
Tdp1(Δ148) cross-linking to DNA oligonucleotides. Equimolar amounts of
Tdp1 (Δ148, H263A) and a DNA oligonucleotide (5IdU(−2), 5IdU(−3) or
unmodiﬁed control oligonucleotide, with the sequences shown in Table 1) were
mixed in buffer containing 10 mM Tris-HCl, pH 7.5 and 100 mM KCl to a ﬁnal
concentration of 5 µM in 500 µl. Prior to cross-linking, samples were incubated at
room temperature for 15 min and then on ice for 15 min. Samples were irradiated
at 312 nm on ice for 30 min using a UV transilluminator (Vilber-Lourmat T-8M
UV-B bulbs).
For SDS-PAGE analysis of cross-linking reactions, 40 µl of each cross-linked
sample was mixed with 10 µl 5x Laemmli Buffer (312.5 mM Tris-HCl, pH 6.8, 10%
SDS, 50% glycerol, 25% β-mercaptoethanol and 0.005% bromophenol blue) and
heated at 95 °C for 3 min. Samples were separated by 8% SDS-PAGE, prepared
using the Protogel Kit (EC-890, National Diagnostics). To visualise protein, gels
were stained with SimplyBlue™ SafeStain (LC6060, Invitrogen, Life Technologies).
For visualisation of DNA on SDS-PAGE, cross-linking reactions were spiked with a
small amount of 5′ 32P-labelled oligonucleotide. Oligonucleotides were 5′ end
labelled with 32P using T4 polynucleotide kinase (PNK, NEB M0201) and [γ-32P]
ATP (Perkin Elmer NEG002A250UC) in standard 20 μl labelling reactions (10
pmol oligonucleotide, 2 μl PNK buffer, 3 μl [γ-32P] ATP, 30 min at 37 °C, followed
by inactivation of PNK at 65 °C for 20 min). Gels were transferred onto Whatman
3MM paper, dried under vacuum at 60 °C for 3 h and analysed using a Storm
PhosphorImager and the ImageQuant software (GE Healthcare).
Capture and enrichment of Tdp1(Δ148)–DNA heteroconjugates. Tdp1
(Δ148)–DNA heteroconjugates were enriched and separated from non-cross-
linked oligonucleotides by capture on magnetic Dynabeads® (His-tag Isolation and
Pulldown, 10103D, Invitrogen, USA) via the Tdp1(Δ148) N-terminal 6-histidine
tag. Dynabeads® (125 µl per sample) were washed three times with 1 ml of Binding
Buffer (300 mM NaCl, 50 mM sodium phosphate pH 8.0), before addition of cross-
linked sample (500 µl) and incubation at room temperature for 30 min in 750 µl of
2× Binding Buffer and 250 µl H2O. Dynabeads® were washed twice with 1 ml
Binding Buffer, then three times with 1 ml 50 mM ammonium bicarbonate.
On-bead trypsin digestion. Tdp1(Δ148)–DNA heteroconjugates immobilised on
Dynabeads® (370 µl in 50 mM ammonium bicarbonate) were reduced in 500 µM
DTT at 50 °C for 15 min, then alkylated in 1 mM iodoacetamide at room tem-
perature for 15 min in the dark. Samples were then digested with 5 µg of
sequencing grade trypsin (V5111, Promega) at 37 °C for 20 h. Supernatant con-
taining tryptic peptides and heteroconjugates was removed from the beads and
phenylmethanesulfonyl ﬂuoride added to 1 mM to inactivate trypsin.
Avidin enrichment. Binding of the trypsin-digested heteroconjugates to mono-
meric avidin (via the 3′ biotin DNA adduct) enabled their enrichment and the
removal of non-cross-linked peptides. To equilibrate the Monomeric Avidin
UltraLink Resin (53146, Pierce), 100 µl of slurry (per sample) was washed 3x with
500 µl of 50 mM ammonium bicarbonate in a 0.8 ml microcentrifuge column
(89868, Pierce), with centrifugation at 1000 × g for 30 s at each step. The mono-
meric avidin resin was then incubated with trypsin-digested samples in closed
centrifuge columns at room temperature for 1 h while mixing, then washed 3x with
500 µl of 50 mM ammonium bicarbonate. Bound heteroconjugates were eluted
with 2 × 300 µl of 2 mM D-biotin in 50 mM ammonium bicarbonate, dried in a
speed vac and re-suspended in 30 µl H2O.
Mass spectrometry of Tdp1(Δ148)–DNA heteroconjugates. Samples were
analysed by negative mode C18-HPLC-ESI-FTICR mass spectrometry, as described
previously for the analysis of heteroconjugates36, using reverse-phase high-
performance liquid chromatography (RP-HPLC) and an U3000 HPLC system
(Dionex, UK) coupled to the standard electrospray source (Bruker Daltonics) and a
SolariX FTICR mass spectrometer equipped with a 12T superconducting magnet
(Bruker Daltonics). Acquisition of LC/MS data was controlled by HyStar, version
3.4, build 8 (Bruker Daltonics).
RP-HPLC was performed using a C18 column (Kinetex 2.6 μm C18 100 Å, LC
Column 100 × 2.1 mm, 00D-4462-AN, Phenomenex, CA, USA). Heteroconjugates
were analysed in negative mode using buffer A (100 mM 1,1,1,3,3,3-hexaﬂuoro-2-
propanol (HFIP), 4 mM triethylamine in 5% methanol), and buffer B (100 mM
HFIP, 4 mM triethylamine in 100% methanol). The column was run using a ﬂow
rate of 200 μl min−1. In the ﬁrst 5 min of the run, a linear ramp from 5% B to 10% B
was diverted to waste. From 5 to 20 min, a linear ramp to 30% B was followed by a
ﬁnal ramp to 60% B from 20 to 25 min. The column was washed with 100% B for 2
min and then 5% B for 3 min. For electrospray ionisation, gas pressure was
typically ∼2.2 psi and spray voltage was ∼4.5 kV. For mass spectrometry, ion
accumulation times were typically 0.3 s. Ions were trapped using a 6 cm × 10 cm
inﬁnity cell. Each individual LC/MS spectrum was the sum of two acquisitions.
Transient data size was typically 1 or 2 Mword for each acquisition, and sine-bell
multiplication apodization was applied to each transient during FT-MS
postprocessing. DNA-containing heteroconjugates were detected by their
absorbance at UV 260 nm and corresponding mass spectrum. For each sample, a
single fraction was collected from 15 to 17 min, from an identical RP-HPLC run
without MS. A control sample, from the cross-linking reaction with unmodiﬁed
oligonucleotide, was collected at the equivalent time interval. All samples were then
dried in a speed vac prior to nuclease P1 digestion.
Nuclease P1 digestion of heteroconjugates. Nuclease P1 (250 units, N8630,
Sigma-Aldrich) was dissolved in 1 ml of H2O. Heteroconjugate samples were
reconstituted in a volume of 20 μl containing 50 mM ammonium acetate, pH 5.2,
and 100 nM ZnCl2 and 0.1 units of nuclease P1 and incubated for 30 min at 50 °C.
Mass spectrometric analysis of digested heteroconjugates. For ofﬂine direct
infusion of nuclease P1-digested heteroconjugates, samples were desalted using a
ZipTipC18 (Millipore) with buffer A (0.1% formic acid) and buffer B (0.1% formic
acid/50% acetonitrile). Electrospray ionisation in positive mode was achieved using
the Triversa NanoMate (Advion BioSciences) operated in infusion mode coupled
to a SolariX FTICR mass spectrometer. Gas pressure was typically ∼0.65 psi, and
spray voltage was ∼1.5 kV. Direct infusion spectra were typically the sum of
100–200 acquisitions. Fragmentation was performed using collision-induced
fragmentation in the collision cell. All mass spectra were analysed using Data
Analysis software version 4.1 SR1 build 362.7 (Bruker Daltonics). Product ions
were calculated and assigned manually.
Fluorescence-based Tdp1(Δ148) cleavage assays. Two DNA substrates (named
HEI-40 and HEI-50, Table 1) with 5′ 5(6)-carboxyﬂuorescein (56-FAM) and 3′
Black Hole Quencher (3BHQ) modiﬁcations were purchased from Integrated DNA
Technologies. Each was dissolved to 50 μM in 10 mM Tris pH 8.0 and 50 mM
NaCl. The sequence of the 34 nt HEI-50 is self-complementary, apart from the
central 4 nt, and can form a 15 bp double-stranded hairpin structure. To promote
hairpin formation and to prevent formation of dimers, HEI-50 was heated to 80 °C
for 10 min and snap-cooled rapidly on ice. The sample was analysed on a 12% (w/
v) native polyacrylamide gel and the mobility was compared to 16 bp dsDNA and
36 bp dsDNA substrates (Supplementary Fig. 4).
Fluorescence-based Tdp1(Δ148) activity assays were carried out in 96-well
black opaque plates (Greiner Bio-One). Each sample (100 μl) contained 50 nM
DNA in reaction buffer (100 mM KCl, 10 mM Tris pH 7.5, 1 mM EDTA, 1 mM
DTT, 100 μg ml−1 BSA). Tdp1(Δ148) was added last to a ﬁnal concentration of 50
nM or 100 nM in reactions containing the single-stranded or hairpin DNA
substrates, respectively. Reactions proceeded for 90 min at 25 °C. The ﬂuorophore
was excited at 488 nm and its emission was measured at 523 nm every 30 s on a
SpectraMax M5 multi-mode microplate reader (Molecular Devices) using
SoftMaxPro software. The data were processed in Microsoft Excel and graphs
plotted in GraphPad Prism.
Preparation of double-stranded DNA substrates for crystallisation. Two
synthetic 12-mer DNA oligonucleotides (Integrated DNA Technologies, Belgium),
with the self-complementary sequences 5′ CAC TGC GCA GTG and 5′ CAA TGC
GCA TTG (Fig. 5b), were dissolved to 1 mM in buffer comprising 10 mM Tris pH
8.0 and 50 mM NaCl. Each oligonucleotide was annealed to an identical strand by
heating to 90 °C for 10 min and then cooling in the heat block to room temperature
over 12 h. To conﬁrm annealing, samples were separated on a 20% native poly-
acrylamide gel, stained with methylene blue and the mobility compared with the
single-stranded 12-mer, a single-stranded 16-mer and a double-stranded 14-mer
control.
Preparation of the Tdp1(Δ148):DNA complexes for crystallisation. Tdp1
(Δ148) complexes with duplex DNA (named −2G or −2T, according to the DNA
sequence) were formed by discontinuous diaﬁltration. Tdp1(Δ148) (100 μl at 55
μM in storage buffer) was diluted into 400 μl of a 22 μM 12-mer duplex DNA in
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-02530-z ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:24 |DOI: 10.1038/s41467-017-02530-z |www.nature.com/naturecommunications 11
crystallisation buffer containing 50 mM HEPES pH 7.8, 50 mM NaCl. After
incubation on ice for 30 min, the sample was added to a 5000 MCO Vivaspin (500
μl, Sartorius Stedium Biotech), repeatedly concentrated ﬁvefold and then diluted in
crystallisation buffer until >99% buffer exchange had been achieved. The ﬁnal
concentration of the complex was 110 μM.
Crystallisation. Crystals were grown by sitting-drop vapour-diffusion in MRC
maxi 48-well crystallisation plates (Swissci). The drops contained 1.5 μl of Tdp1
(Δ148):DNA complex (110 μM) and 1.5 μl of well solution comprising 0.1 M
ammonium sulphate, 0.1 M HEPES pH 7.5 and 25% (w/v) PEG 8000. The crystals
were brieﬂy immersed in well solution supplemented with 10% (v/v) glycerol prior
to cooling in liquid nitrogen for X-ray diffraction experiments.
X-ray crystal structure determination and reﬁnement. X-ray diffraction data
were collected on beam line I04 at the Diamond Light Source. The wavelength of
the X-rays was 0.9795 Å and 0.92891 Å for the Tdp1 (Δ148) complex with the −2G
or the −2T DNA duplex, respectively. Crystals displayed orthorhombic (P21212)
symmetry and diffracted X-rays to a maximum resolution of 2.04 Å. The X-ray
diffraction data were processed with xia2 and the statistics are shown in Table 2.
Initial phases were determined by molecular replacement, using the structure of the
apo form of Tdp1(Δ148) (PDB ID: 1JY1) as the search model in PHASER. The
DNA structure was built manually in Coot. Restrained reﬁnement was performed
with Refmac5 and Coot. The reﬁnement statistics are shown in Table 2. For the
Tdp1 (Δ148) −2G DNA complex, 96% of the amino acids were in the preferred
region of the Ramachandran plot, and the remaining 4% were in the allowed
region. For the Tdp1 (Δ148) −2T DNA complex, 97% of the amino acids were in
the preferred region of the Ramachandran plot, and the remaining 3% were in the
allowed region. All structural diagrams were prepared using PyMOL (http://www.
pymol.org/) and Adobe Illustrator.
Determination of DNA length in crystal by denaturing PAGE. The 12-mer
substrate oligonucleotide −2G 12-mer and ﬁve size-marker oligonucleotides, ranging
from 7 to 11 nts (with the sequences shown in Table 1), were 5′ end labelled with 32P
in standard 20 μl labelling reactions as described above. In order to generate a 3′-
phosphorylated 11-mer from the 12-mer, 1 pmol of 32P-labelled 12-mer was incu-
bated with 3 μg Tdp1(Δ148) in a total volume of 10 μl at 37 °C for 1 h in Tdp1
reaction buffer (100mM KCl, 10mM Tris-HCl pH 7.5, 1mM EDTA, and 1mM
DTT). The reaction was stopped by addition of 10 μl of formamide-loading dye (96%
formamide, 20mM EDTA, 0.03% xylene cyanol and 0.03% bromophenol blue).
A corresponding 5′ end-labelled 11-mer with a 3′ hydroxyl was generated by
ﬁrst incubating 1 pmol of unlabelled 12-mer with 3 μg Tdp1(Δ148) in a total
volume of 10 μl at 37 °C for 1 h, then at 95 °C for 5 min. The resulting 11-mer with
a 3′ phosphate was then incubated with PNK, as described above, which adds a 5′
32P-label and removes the 3′ phosphate generating a 3′ hydroxyl end. Reactions
were stopped with at least an equal volume of formamide-loading dye.
A crystal of the Tdp1(Δ148):DNA complex containing the 12-mer double-
stranded DNA oligonucleotide sc12mer_G(-2), grown for ~80 days at 17 °C, was
washed twice in crystallisation well solution and then dissolved in 1 μl of water to
an estimated DNA oligonucleotide concentration of 0.5 pmol μl−1. This DNA was
5′ end labelled in a total volume of 10 μl by incubating with 0.5 μl of PNK and 0.75
μl [γ-32P] ATP at 37 °C for 30 min, and then at 65 °C for 20 min to inactivate PNK.
One μl of the labelling reaction containing ~50 fmol oligonucleotide was added to
4 μl of formamide-loading dye and used for analysis.
All samples were denatured for 3 min at 95 °C and 5 μl of each, containing 50
fmol oligonucleotide, were separated on 20% denaturing UREA PAGE as
described47. Image retrieval was carried out using a PhosphorImager and
IMAGEQUANT software (Molecular Dynamics).
Data availability. The X-ray data generated during this study are available as
public data sets at the RCSB protein databank with accession numbers 5NW9 and
5NWA. The biochemical data and mass spectrometry data are available as public
data sets48,49 at the University of Edinburgh DataShare repository at https://doi.
org/10.7488/ds/2237 and https://doi.org/10.7488/ds/2243, respectively. All data are
also available from the corresponding authors on request.
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